JP2025535941A5 - - Google Patents
Info
- Publication number
- JP2025535941A5 JP2025535941A5 JP2025523885A JP2025523885A JP2025535941A5 JP 2025535941 A5 JP2025535941 A5 JP 2025535941A5 JP 2025523885 A JP2025523885 A JP 2025523885A JP 2025523885 A JP2025523885 A JP 2025523885A JP 2025535941 A5 JP2025535941 A5 JP 2025535941A5
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- compressible
- compressed
- tablet according
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025191860A JP2026027432A (ja) | 2022-11-03 | 2025-11-12 | イブタモレンの圧縮型経口製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263422329P | 2022-11-03 | 2022-11-03 | |
| US63/422,329 | 2022-11-03 | ||
| PCT/US2022/050700 WO2024096892A1 (en) | 2022-11-03 | 2022-11-22 | Compactable oral formulations of ibutamoren |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025191860A Division JP2026027432A (ja) | 2022-11-03 | 2025-11-12 | イブタモレンの圧縮型経口製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025535941A JP2025535941A (ja) | 2025-10-30 |
| JP2025535941A5 true JP2025535941A5 (enExample) | 2025-11-20 |
| JP7872443B2 JP7872443B2 (ja) | 2026-06-09 |
Family
ID=90835855
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025523885A Active JP7872443B2 (ja) | 2022-11-03 | 2022-11-22 | イブタモレンの圧縮型経口製剤 |
| JP2025191860A Pending JP2026027432A (ja) | 2022-11-03 | 2025-11-12 | イブタモレンの圧縮型経口製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025191860A Pending JP2026027432A (ja) | 2022-11-03 | 2025-11-12 | イブタモレンの圧縮型経口製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11969416B1 (enExample) |
| EP (1) | EP4611737A1 (enExample) |
| JP (2) | JP7872443B2 (enExample) |
| KR (1) | KR20250107210A (enExample) |
| CN (1) | CN120239602A (enExample) |
| AU (1) | AU2022485048A1 (enExample) |
| CL (1) | CL2025001309A1 (enExample) |
| CO (1) | CO2025007025A2 (enExample) |
| GE (1) | GEAP202516774A (enExample) |
| IL (1) | IL320529A (enExample) |
| MX (1) | MX2025005154A (enExample) |
| WO (1) | WO2024096892A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEAP202516774A (en) | 2022-11-03 | 2025-06-25 | Lumos Pharma Inc | Compactable oral formulations of ibutamoren |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128143A (en) * | 1988-09-19 | 1992-07-07 | Edward Mendell Co., Inc. | Sustained release excipient and tablet formulation |
| US6123964A (en) | 1995-10-27 | 2000-09-26 | Merck & Co., Inc. | Wet granulation formulation of a growth hormone secretagogue |
| JPH11513989A (ja) | 1995-10-27 | 1999-11-30 | メルク エンド カンパニー インコーポレーテッド | 成長ホルモン分泌促進薬の湿式造粒製剤 |
| CA2420535A1 (en) * | 2000-08-30 | 2002-03-07 | Mary Tanya Am Ende | Sustained release formulations for growth hormone secretagogues |
| WO2003090723A1 (en) * | 2002-04-23 | 2003-11-06 | Bristol-Myers Squibb Company | Modified-release vasopeptidase inhibitor formulation, combinations and method |
| ES2710665T3 (es) * | 2006-03-15 | 2019-04-26 | Michael O Thorner | Métodos para el tratamiento de la sarcopenia con un secretagogo de hormona de crecimiento |
| FI20080351A0 (fi) | 2008-05-09 | 2008-05-09 | Atacama Labs Oy | Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi |
| WO2014030204A1 (ja) * | 2012-08-20 | 2014-02-27 | 大日本住友製薬株式会社 | 薬物含有中空粒子 |
| CA2889499C (en) * | 2012-10-24 | 2019-09-10 | Daiichi Sankyo Company, Limited | Growth hormone secretagogue receptor agonists for treating amyotrophic lateral sclerosis |
| MX378261B (es) * | 2013-03-14 | 2025-03-10 | Redhill Biopharma Ltd | Formas de dosificación sólidas de liberación prolongada antieméticas. |
| CA2845443A1 (en) * | 2014-03-04 | 2015-09-04 | Pharmascience Inc. | Orally disintegrating tablet of nabilone and method of manufacturing |
| CN108348501A (zh) * | 2015-09-21 | 2018-07-31 | 埃莫奈特药业有限责任公司 | 检测和治疗生长激素缺乏症 |
| EP4467158A3 (en) * | 2018-02-14 | 2025-02-19 | Lumos Pharma, Inc. | Compositions for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis |
| GEAP202516774A (en) | 2022-11-03 | 2025-06-25 | Lumos Pharma Inc | Compactable oral formulations of ibutamoren |
-
2022
- 2022-11-22 GE GEAP202516774A patent/GEAP202516774A/en unknown
- 2022-11-22 CN CN202280101646.1A patent/CN120239602A/zh active Pending
- 2022-11-22 US US18/057,941 patent/US11969416B1/en active Active
- 2022-11-22 WO PCT/US2022/050700 patent/WO2024096892A1/en not_active Ceased
- 2022-11-22 IL IL320529A patent/IL320529A/en unknown
- 2022-11-22 KR KR1020257018282A patent/KR20250107210A/ko active Pending
- 2022-11-22 JP JP2025523885A patent/JP7872443B2/ja active Active
- 2022-11-22 EP EP22964610.4A patent/EP4611737A1/en active Pending
- 2022-11-22 AU AU2022485048A patent/AU2022485048A1/en active Pending
-
2024
- 2024-04-01 US US18/623,761 patent/US12390452B2/en active Active
-
2025
- 2025-05-02 CL CL2025001309A patent/CL2025001309A1/es unknown
- 2025-05-02 MX MX2025005154A patent/MX2025005154A/es unknown
- 2025-05-27 CO CONC2025/0007025A patent/CO2025007025A2/es unknown
- 2025-11-12 JP JP2025191860A patent/JP2026027432A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106943355B (zh) | 药物组合物 | |
| RU2616516C2 (ru) | Фармацевтическая композиция, содержащая олмесартана медоксомил и розувастатин или его соль | |
| US5814339A (en) | Film coated tablet of paracetamol and domperidone | |
| WO2011111818A1 (ja) | モサプリドまたはその塩を含む徐放型医薬組成物 | |
| WO2010140111A1 (en) | Pharmaceutical compositions containing a combination of an antihistamine and a decongestant | |
| JP2022553313A5 (enExample) | ||
| WO2012018056A1 (ja) | 圧縮組成物 | |
| JP2023536667A5 (enExample) | ||
| JP2022540348A5 (enExample) | ||
| JP7212484B2 (ja) | 腸溶性被覆顆粒の耐酸性が改善された圧縮成形製剤の製造方法 | |
| MX2013010598A (es) | Composiciones farmaceuticas de liberacion controlada de inhibidor de recaptacion de serotonina selectivo. | |
| AU2016231883A1 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| US20060002997A1 (en) | Nitrofurantoin controlled release dosage form | |
| US20180344648A1 (en) | Clobazam tablet formulation and process for its preparation | |
| WO2010120963A1 (en) | Tablet formulation for p38 inhibitor and method | |
| JP2024503689A5 (enExample) | ||
| EP3496719B1 (en) | A multi-class anti-retroviral composition | |
| JP2021518422A (ja) | レナリドミドを含む医薬組成物 | |
| JP7362302B2 (ja) | レベチラセタムを含有する錠剤とその製造方法 | |
| JP5123471B2 (ja) | 用量調整が容易な製剤 | |
| JP7404828B2 (ja) | 経口医薬製剤およびその製造方法 | |
| JP5910311B2 (ja) | 医薬錠剤およびその製造方法 | |
| JP7423297B2 (ja) | 口腔内崩壊錠およびその製造方法 | |
| JP2021518424A (ja) | 様々な用量のレナリドミドの経口用錠剤組成物 | |
| JP2019137669A (ja) | 相対的高密度顆粒を含有する圧縮成形錠剤の工業的製造方法 |